跳至主要内容
临床试验/NCT03855267
NCT03855267Unknown不适用

Effects of Etomidate/Propofol Mixture or Propofol Monotherapy With Different Proportions on Circulation and Prognosis in Patients Undergoing General Anesthesia

Guolin Wang1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
blood pressure

研究概览

简要总结

The purpose of this study was to investigate the effects of different proportions of etomidate/propofol mixture and propofol alone intravenous anesthesia on intraoperative and postoperative physiological indicators and complications, and to find out the optimal use ratio of E/P mixture.

详细描述

Propofol is one of the most commonly used intravenous anesthesia drugs clinically, the pharmacokinetic characteristics makes it very suitable for total intravenous anesthesia( TIVA), etomidate belongs to intravenous anesthesia with propofol, is a derivative of the imidazoles, its calm performance is strong, work quickly, no obvious respiratory depression, had little effects on the cardiovascular system, which, therefore, to protect the cardiovascular, maintain hemodynamic stability has a certain advantage. Our previous project showed that propofol and etomidate combined application can maintain stable hemodynamics in patients with better, reduce the occurrence of adverse reactions, can be used within 3 h of surgery anesthesia.The purpose of this study is to use propofol or etomidate/propofol mixture in combination with BIS monitoring to perform general anesthesia maintenance for patients, in order to ensure the appropriate depth of anesthesia, better maintain the hemodynamic stability of patients, reduce adverse reactions, and find the appropriate E/P mixture of the best proportion and dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective general anesthesia surgery in 3h;
  • American Society of Anesthesiologists gradesⅠ~III;
  • Aged 18 to 65 years, Body Mass Index 18.5 ~ 29.9kg / m2;
  • Hemoglobin 100 ~ 125g / L.
  • In line with the ethics, the patients volunteered to take the test and signed the informed consent

排除标准

  • Identify or suspect abuse or chronic use of narcotic sedatives and analgesics;
  • Heart, or liver, or lung, or kidney dysfunction;
  • Body mass index> 30kg / m2; or <18.5kg / m2
  • Speech, hearing or mental disorders;
  • severe diabetes, hyperkalemia ;
  • participate in other drug clinical researches in four weeks;
  • Poor compliance, can not complete clinical research by research program.
  • Any cerebrovascular accident occurred within 3 months, such as stroke, TIA, etc
  • Unstable angina and myocardial infarction occurred within 3 months;
  • Having contraindications or allergies to experimental drugs and other narcotic drugs;
  • Mental illness, hyperkalemia.

研究组 & 干预措施

Group A

Placebo Comparator

Propofol 20 mg/ml, recommended anesthesia induction dose of 0.1~0.125 ml/kg, anesthesia maintenance pump speed of 0.2~0.5ml/kg/h. keep bispectral index within 40 # 60

干预措施: Propofol 20 MG/ML (Drug)

GroupB

Active Comparator

EP1:3, that is, 10ml etomidate was mixed with 30ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.

干预措施: Propofol 20 mg/ml , etomidate 2 mg/ml (Drug)

Group C

Active Comparator

EP1:1, that is, 20ml etomidate was mixed with 20ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.

干预措施: Propofol 20 mg/ml , etomidate 2 mg/ml (Drug)

Group D

Active Comparator

EP3:1, that is, 30ml etomidate was mixed with 10ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.

干预措施: Propofol 20 mg/ml , etomidate 2 mg/ml (Drug)

结局指标

主要结局

blood pressure

时间窗: intraoperative

the blood pressure is recorded (mmHg)

heart rate

时间窗: intraoperative

the heart rate is recorded(bpm)

次要结局

  • Perioperative complications(intraoperative)

研究者

发起方
Guolin Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Guolin Wang

Tianjin Medical University General Hospital

Tianjin Medical University General Hospital

研究点 (1)

Loading locations...

相似试验

Etomidate/Propofol Mixture or Propofol Monotherapy... | 临床试验